Osteoboost has released findings from “The Menopause Bone Health Gap,” an independent research study highlighting gaps in bone loss prevention and treatment awareness.
The company, which has developed the first FDA-cleared vibrational device for osteopenia treatment, surveyed 1,053 US women to assess bone health awareness. The findings revealed that many women are unaware of osteoporosis-related fracture risks and how to support long term bone health.
Nearly 25% of survey respondents were surprised to learn that half of women over 50 will break a bone due to osteoporosis. Meanwhile, prevention options require further education – nearly half said they would take vitamin D to protect their bones, while just 28% started strength training. Similarly, care remains inaccessible, as almost 20% had avoided seeing a physician or getting a bone scan due to cost.
“Menopause has finally become part of the mainstream health conversation, but bone health is too often left out of it,” said Laura Yecies, CEO of Osteoboost Health. “That knowledge gap has lasting consequences. Half of women’s lifetime bone loss occurs during the menopause transition, and even our most powerful osteoporosis medications cannot fully rebuild what has already been lost. Women need earlier, clearer information about their bone health status, fracture risk and the full range of evidence-based steps they can take to protect their bones.”
